The Cognitive Footprint of Medication Use
Brain and Behavior · 2025
DOI: 10.1002/brb3.70200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Marta Suárez Pinilla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neuroscience Laboratory, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Cognition, Drug-Related Side Effects and Adverse Reactions, Cognition Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Health Foundation, National Institute for Health and Care Research.
Abstract (Originalsprache)
Introduction
The cognitive side‐effects of medication are common, but often overlooked in practice, and not routinely considered in interventional trials or post‐market surveillance. The cognitive footprint of a medication seeks to quantify the impact of its cognitive effects based on magnitude, duration, and interaction with other factors, evaluated across the exposed population.
Methods
Bayesian multivariable regression analysis of retrospective population‐based cross‐sectional cohorts.
Results
We replicate positive and negative cognitive effects of commonly used medications in UK Biobank, and extend observed associations to two additional cohorts, the EPIC Norfolk, and the Caerphilly Prospective Cohort. We quantify the resultant cumulative impact at the population level given known patterns of prescribing and compare it with exemplar common diseases.
Conclusion
The cognitive side‐effects of commonly used drugs may have significant impact at the population level. Consideration should be given to a routine structured assessment of cognition in interventional trials and post‐market surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Neuroscience Laboratory, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.
- UCL Queen Square Institute of Neurology, University College London, London, UK.
- Centre for Chronic Illness and Ageing, School of Human Sciences, University of Greenwich, Park Row, London.
- Health Policy Department, London School of Economics and Political Science, London, UK.
ORCID-Profile: Martin Rossor
Förderung
- Wellcome Trust
- Health Foundation
- National Institute for Health and Care Research
Zitieren
APA
Pinilla, M. S., Stoner, C. R., Knapp, M., Nachev, P., & Rossor, M. (2025). The Cognitive Footprint of Medication Use. Brain and Behavior. https://doi.org/10.1002/brb3.70200
Vancouver
Pinilla MS, Stoner CR, Knapp M, Nachev P, Rossor M. The Cognitive Footprint of Medication Use. Brain and Behavior. 2025. doi:10.1002/brb3.70200
BibTeX
@article{Pinilla2025,
author = {Pinilla, Marta Suárez and Stoner, Charlotte R and Knapp, Martin and Nachev, Parashkev and Rossor, Martin},
title = {The Cognitive Footprint of Medication Use},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70200}
}
EUVIMED